The BNP assay does not identify mild left ventricular diastolic dysfunction in asymptomatic diabetic patients

European Journal of Echocardiography

Volumn 7, Issue 1, 2006, Pages 40-44

  Valle, Robeto ^a   Bagolin, E ^a   Canali, C ^a   Giovinazzo, P ^a   Baro, S ^a   Aspromonte, N ^b   Carbonieri, E ^c   Milani, L ^a  

^a Ospedale Civile   (Italy)

^b SPIRITO SANTO HOSPITAL   (Italy)

^c San Bonifacio Hospital   (Italy)

Author keywords

B type natriuretic peptide; Diabetes mellitus; Diastolic dysfunction

Indexed keywords

BIOCHEMICAL MARKER; BRAIN NATRIURETIC PEPTIDE;

ADULT; AGED; ARTICLE; DIABETIC ANGIOPATHY; DISEASE SEVERITY; DOPPLER ECHOCARDIOGRAPHY; FEMALE; FLUORESCENCE; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN DETERMINATION; SCREENING TEST; SYMPTOMATOLOGY;

AGED; ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CREATININE; DIABETES MELLITUS, TYPE 2; DIASTOLE; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; FLUORESCENCE POLARIZATION IMMUNOASSAY; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; VENTRICULAR DYSFUNCTION, LEFT;

EID: 30844439644     PISSN: 15252167     EISSN: 15322114     Source Type: Journal    
DOI: 10.1016/j.euje.2005.03.009     Document Type: Article

References (29)

1. P. Di Bonito S. Cuomo N. Moio G. Sibilio D. Sabatini S. Quattrin et al. Diastolic dysfunction in patients with NIDDM of short duration Diabet Med 13 1996 321-324
2. J.J. Sanchez-Barriga A. Rangel R. Castaneda D. Flores A.C. Frati M.A. Ramos et al. LV diastolic dysfunction secondary to hyperglycemia in patients with type 2 diabetes Arch Med Res 32 2001 44-47
3. T. Beljic M. Miric Improved metabolic control does not reverse LV filling abnormalities in newly diagnosed NIDDM patients Acta Diabetol 31 1994 147-150
4. M. Diamant H.J. Lamb Y. Groeneveld E.L. Endert J.W. Smit J.J. Bax et al. Diastolic dysfunction is associated with altered myocardial metabolism in asymptomatic normotensive patients with well-controlled type 2 diabetes mellitus J Am Coll Cardiol 42 2003 328-335
5. W.B. Kannel M. Hjortland W.P. Castelli Role of diabetes in congestive heart failure: The Framingham study Am J Cardiol 34 1974 29-34
6. J.S. Gottdiener A.M. Arnold G.P. Aurigemma J.F. Polak R.P. Tracy D.W. Kitzman et al. Predictors of congestive heart failure in the elderly: the Cardiovascular Health Study J Am Coll Cardiol 35 2000 1628-1637
7. Y.T. Chen V. Vaccarino C.S. Williams J. Butler L.F. Berkman H.M. Krumholz et al. Risk factors for heart failure in the elderly: A prospective community-based study Am J Med 106 1999 605-612
8. D.S. Bell Heart failure: The frequent, forgotten, and often fatal complication of diabetes Diabetes Care 26 2003 2433-2441
9. C.M. Francis L. Caruana P. Kearney M. Love G.R. Sutherland I.R. Starkey et al. Open access echocardiography in management of heart failure in the community Br Med J 310 1995 634-636
10. V. Epshteyn K. Morrison P. Krishnaswamy R. Kazanegra P. Clopton S. Mudalier et al. Utility of B-Type natriuretic peptide (BNP) as a screen for left ventricular dysfunction in patients with diabetes Diabetes Care 26 2003 2081-2087
11. K. Maeda T. Tsutamoto A. Wada T. Hisanaga M. Kinoshita Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction Am Heart J 135 1998 825-832
12. A.S. Maisel J. Koon P. Krishnaswamy R. Kazanegra P. Clopton N. Gardetto et al. Utility of B-natriuretic peptide (BNP) as a rapid, point-of-care test for screening patients undergoing echocardiography for left ventricular dysfunction Am Heart J 141 2001 367-374
13. P. Krishnaswamy E. Lubien P. Clopton J. Koon R. Kazanegra E. Wanner et al. Utility of B-natriuretic peptide (BNP) in elucidating left ventricular dysfunction (systolic and diastolic) in patients with and without symptoms of congestive heart failure at a Veterans hospital Am J Med 111 2002 274-279
14. E. Lubien A. DeMaria P. Krishnaswamy P. Clopton J. Koon R. Kazanegra et al. Utility of B-natriuretic peptide in detecting diastolic dysfunction: comparison with Doppler velocity recordings Circulation 105 2002 595-601
15. http://www.siditalia.it - Linee Guida per la prevenzione cardiovascolare del paziente diabetico.
16. P.A. McKee W.P. Castelli P.M. McNamara W.B. Kannel The natural history of CHF. The Framingham study N Engl J Med 285 1971 1442-1446
17. M.J. Garcia J.D. Thomas A.L. Klein New Doppler echocardiographic applications for the study of diastolic function J Am Coll Cardiol 32 1998 865-875
18. R.W. Troughton D.L. Prior J.J. Pereira Plasma B-type natriuretic peptide levels in systolic heart failure importance of left ventricular diastolic function and right ventricular systolic function J Am Coll Cardiol 43 2004 416-422
19. B. Kuch H.W. Hense B. Gneiting A. Doring M. Muscholl U. Brockel et al. Body composition and prevalence of left ventricular hypertrophy Circulation 102 2000 405-410
20. B.I. Seneviratne Diabetic cardiomyopathy: The preclinical phase Br Med J 1 1977 1444-1446
21. D.C. Raev Which left ventricular function is impaired earlier in the evolution of diabetic cardiomyopathy? An echocardiographic study of young type I diabetic patients Diabetes Care 17 1994 633-639
22. J. Piccini L. Klein M. Gheorghiade R.O. Bonow New insights into diastolic heart failure: Role of diabetes mellitus Am J Med 116 5A 2004 64S-75S
23. M. Senni M.M. Redfield Heart failure with preserved systolic function. A different natural history? J Am Coll Cardiol 38 2001 1277-1282
24. S. Yusuf M.A. Pfeffer K. Swedberg C.B. Granger P. Held J.J. McMurray et al. Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: The CHARM-Preserved Trial Lancet 362 2003 777-781
25. D.E. Forman W.J. Manning R. Hauser E.V. Gervino W.J. Evans J.Y. Wei et al. Enhanced LV diastolic filling associated with long-term endurance training J Gerontol 47 1992 M56-M58
26. U. Hoffmann S. Globits T. Stefenelli C. Loewe K. Kostner H. Frank et al. The effects of ACE inhibitor therapy on LV myocardial mass and diastolic filling in previously untreated hypertensive patients: A cine MRI study J Magn Reson Imaging 14 2001 16-22
27. C. Iribarren A.J. Karter A.S. Go A. Ferrara J.Y. Liu S. Sidney et al. Glycemic control and heart failure among adult patients with diabetes Circulation 103 2001 2668-2673
28. U. Dahlstrom Can natriuretic peptides be used for the diagnosis of diastolic heart failure? Eur J Heart Fail 2004 6 2004 281-287
29. Z.Y. Fang R. Schull-Meade R. Leano P.M. Mottram J.B. Prins T.H. Marwick Screening for heart disease in diabetic subjects Am Heart J 149 2005 349-354